Seed3 April 2023

OSSTEC raises £1.2m seed round to progress smart bone implants to clinical trials

The funding round was led by SFC Capital and OION to prepare the medical device startup for patient trials.

£1.2MSeed

Share allotment filed at Companies House

OSSTEC develops 3D printed titanium bone implants that mimic the porous, living structure of natural bone to improve fixation for younger patients.

Imperial College London spinout OSSTEC has secured £1.2m in a seed funding round to advance its smart bone implants towards clinical trials. The investment was led by SFC Capital and OION, with participation from Science Angel Syndicate, Parkwalk Advisors, Embryo Ventures, and Imperial Enterprise Lab. The company will use the capital to complete regulatory testing and develop prototype implants for upcoming human studies. Founded on mechanical engineering research from Imperial College, OSSTEC uses 3D printing technology to manufacture porous titanium structures designed to integrate naturally with living bone.

From the founder

"A younger patient has about a 35% chance of implant failure during their lifetime, and the leading cause of failure is loss of fixation between the bone and the implant"

Max Munford

Chief Executive at OSSTEC

Investor perspective

"What grabbed my attention as an investor is that OSSTEC not only has an advanced technological solution, but also a credible plan to build a company around it and realise the innovation all the way from the 3D-printer to the operating theatre"

James Groves

Investment Manager, Imperial College Enterprise Fund